OBJECTIVE: To investigate self-administered vaginal swabs for assessing prevalence and correlates of carcinogenic human papillomavirus (HPV) infection in rural Rakai, Uganda. METHODS: 1003 sexually experienced women enrolled in a community cohort provided self-administered vaginal swabs collected at annual, home-based surveys. Carcinogenic HPV prevalence, adjusted odds ratios (AOR), 95% confidence intervals (CI) and associated risk factors were determined. RESULTS: Carcinogenic HPV prevalence was 19.2%: 46.6% among HIV positive and 14.8% among HIV negative women (p<0.001). Type-specific prevalence ranged from 2.0% (HPV 16 and 52) to 0.2% (HPV 31). Age-specific HPV prevalence decreased significantly (p<0.001) among HIV negative women; however, the decrease among HIV positive women was not as pronounced (p = 0.1). Factors independently associated with carcinogenic HPV infection were HIV (AOR 4.82, CI 3.10 to 7.53), age (AOR 4.97, 95% CI 2.19 to 11.26 for 15-19 year olds compared to 40+ years), more than two sex partners in the past year (AOR 2.21, CI 1.10 to 4.43) and self-reported herpes zoster, candidiasis or tuberculosis (AOR 4.52, CI 1.01 to 20.31). Married women were less likely to have prevalent carcinogenic HPV (AOR 0.46, CI 0.30 to 0.70). CONCLUSIONS: HPV prevalence and correlates measured using self-administered vaginal swabs were similar to studies that use cervical samples. Thus, self-collection can be used as a substitute for cervical specimens and provide an important tool for research in populations unwilling to undergo pelvic exam.
OBJECTIVE: To investigate self-administered vaginal swabs for assessing prevalence and correlates of carcinogenic human papillomavirus (HPV) infection in rural Rakai, Uganda. METHODS: 1003 sexually experienced women enrolled in a community cohort provided self-administered vaginal swabs collected at annual, home-based surveys. Carcinogenic HPV prevalence, adjusted odds ratios (AOR), 95% confidence intervals (CI) and associated risk factors were determined. RESULTS:Carcinogenic HPV prevalence was 19.2%: 46.6% among HIV positive and 14.8% among HIV negative women (p<0.001). Type-specific prevalence ranged from 2.0% (HPV 16 and 52) to 0.2% (HPV 31). Age-specific HPV prevalence decreased significantly (p<0.001) among HIV negative women; however, the decrease among HIV positive women was not as pronounced (p = 0.1). Factors independently associated with carcinogenic HPV infection were HIV (AOR 4.82, CI 3.10 to 7.53), age (AOR 4.97, 95% CI 2.19 to 11.26 for 15-19 year olds compared to 40+ years), more than two sex partners in the past year (AOR 2.21, CI 1.10 to 4.43) and self-reported herpes zoster, candidiasis or tuberculosis (AOR 4.52, CI 1.01 to 20.31). Married women were less likely to have prevalent carcinogenic HPV (AOR 0.46, CI 0.30 to 0.70). CONCLUSIONS:HPV prevalence and correlates measured using self-administered vaginal swabs were similar to studies that use cervical samples. Thus, self-collection can be used as a substitute for cervical specimens and provide an important tool for research in populations unwilling to undergo pelvic exam.
Authors: Deepa Reddy; Joseph Njala; Penny Stocker; Alan Schooley; Martiniano Flores; Chi-Hong Tseng; Colin Pfaff; Perry Jansen; Ronald T Mitsuyasu; Risa M Hoffman Journal: Int J STD AIDS Date: 2014-06-13 Impact factor: 1.359
Authors: David Serwadda; Maria J Wawer; Frederick Makumbi; Xiangrong Kong; Godfrey Kigozi; Patti Gravitt; Stephen Watya; Fred Nalugoda; Victor Ssempijja; Aaron A R Tobian; Noah Kiwanuka; Lawrence H Moulton; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Amy E Oliver; Boaz Iga; Oliver Laeyendecker; Ronald H Gray Journal: J Infect Dis Date: 2010-05-15 Impact factor: 5.226
Authors: A Jaquet; A Horo; V Charbonneau; D K Ekouevi; L Roncin; B Toure; P Coffie; A Minga; A J Sasco; I Garrigue; H Fleury; F Dabis Journal: Br J Cancer Date: 2012-07-10 Impact factor: 7.640
Authors: Cecily Banura; Florence M Mirembe; Anne R Katahoire; Proscovia B Namujju; Anthony K Mbonye; Fred M Wabwire Journal: Infect Agent Cancer Date: 2011-07-12 Impact factor: 2.965
Authors: Jean d'Amour Sinayobye; Marc Sklar; Donald R Hoover; Qiuhu Shi; Jean Claude Dusingize; Mardge Cohen; Eugene Mutimura; Brenda Asiimwe-Kateera; Philip E Castle; Howard Strickler; Kathryn Anastos Journal: Infect Agent Cancer Date: 2014-12-08 Impact factor: 2.965